SLCH Announces Clinical Affiliation

(Newburgh) - In its continuing commitment to bring comprehensive, progressive health care services and a variety of medical and surgical subspecialties to our region, St. Luke’s Cornwall Hospital (SLCH) announced its clinical affiliation with The Mount Sinai Hospital. The resources of a medical center internationally acclaimed for excellence in clinical care, education, and scientific research are now accessible in the Mid-Hudson Valley.

“This partnership with Mount Sinai, one of the finest health care institutions in the country, enhances and extends the care SLCH and its physicians can provide to our community,” said Allan E. Atzrott, SLCH President and CEO. This alliance reflects SLCH’s ongoing commitment to excellence, and to providing a full range of services to our region.

“We are very pleased to make the vast resources of Mount Sinai available to St. Lukes Cornwall Hospital and the people it serves,” said Kenneth L. Davis, M.D., President and CEO of The Mount Sinai Medical Center and Dean of Mount Sinai School of Medicine. “SLCH has an excellent reputation, and has done much to bring ‘big-city care’ to the Hudson Valley. Our partnership supports and complements the physicians, technology, and services SLCH currently offers to its community.”

The partnership facilitates the continuum of care for SLCH patients requiring transfer to - or the resources of - a major medical center, and brings additional clinical capabilities to the region. Under the alliance, SLCH patients will have easy access to Mount Sinai’s inpatient and ambulatory tertiary care, as well as primary and secondary level care including the specialties of gynecologic oncology, in vitro fertilization, and kidney transplantation. The arrangement provides for a special service to coordinate physician-to-physician contact, consultations, specialized diagnostic services, and patient transfers.

George Hagopian, M.D., a gynecologic oncologist and Assistant Professor of Obstetrics, Gynecology and Reproductive Services at Mount Sinai School of Medicine, already has joined the SLCH medical staff and is performing cancer surgery at the hospital. In 2006, Mount Sinai’s Division of Gynecologic Oncology became a member of the Gynecologic Oncology Group, the nation’s primary research organization for gynecologic cancer. Pictured Above: Leaders of both hospitals presided over the ceremonial affiliation-agreement signing. Left to right: Richard O’Beirne (Chairman, SLCH Board of Trustees), Allan E. Atzrott (SLCH President and CEO), Kenneth L. Davis, M.D. (President and CEO of The Mount Sinai Medical Center), and Gurinder Mehar, M.D. (President, SLCH Medical Staff).